Back to FDA Applications sponsored by ALCON PHARMS LTD

FDA Drug Application 021114 by ALCON PHARMS LTD

Application Number021114
Application Type New Drug Application
Sponsor ApplicantALCON PHARMS LTD
Most Recent Label Available Flag
Current Patent Flag
Action Type Approval
Chemical Type New ester, new salt, or other noncovalent derivative
Therapeutic Potential Priority
Orphan Code 


  
Action TypeDuplicate CounterAction DateDocument TypeApplication Document IDSequence NumberDocument TitleDocument URLDocument Date
AP02/23/2000N1316000   http://www.accessdata.fda.gov/drugsatfda_docs/label/2000/21114lbl.pdf 2/29/2000
AP02/23/2000N10456000   http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2000/021114_Betaxon_approv.pdf 10/26/2004
AP02/23/2000N11790000   http://www.accessdata.fda.gov/drugsatfda_docs/nda/2000/021114_s000_Betaxon.cfm 6/10/2005
AP09/28/2006SE815034002   http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2006/021114s002LTR.pdf 10/2/2006
AP03/9/2010SLR25013003   http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/021114s003lbl.pdf 3/9/2010
AP03/9/2010SLR25057003   http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2010/021114s003ltr.pdf 3/18/2010
AP06/11/2006SLR       




Back to FDA Applications sponsored by ALCON PHARMS LTD